10,285
Participants
Start Date
January 22, 2022
Primary Completion Date
April 1, 2022
Study Completion Date
October 27, 2022
Aerosolized Ad5-nCoV
Aerosolized Ad5-nCoV is produced by CanSino Biologics Inc. It is a liquid dosage form, 0.1 ml / dose, contains 1×10\^10 virus particles of recombinant replication defective human type 5 adenovirus expressing SARS-CoV-2 S protein, aerosol inhalation.
Inactivated SARS-CoV-2 vaccine
Inactivated SARS-CoV-2 vaccine is homologous to the priming series which have been administered to the subjects, produced by SinoVac Biotech Co,. Ltd, Beijing Institute of Biological Products Co,. Ltd, Wuhan Institute of Biological Products Co,. Ltd, or Biokangtai.
Jiangsu Provincial Center for Diseases Control and Prevention, Nanjing
Anhui Provincial Center for Disease Control and Prevention
UNKNOWN
Shandong Province Centers for Disease Control and Prevention
OTHER
Hunan Provincial Center for Disease Control and Prevention
OTHER
Yunnan Center for Disease Control and Prevention
OTHER
Chongqing Center for Disease Control and Prevention
OTHER
Jiangsu Province Centers for Disease Control and Prevention
NETWORK